In conclusion, using the new modeling concept and statistical method, an extended Cox prognostic model for the prognosis of ER/PR+ and HER2− breast cancer was explored while determining the cutoff points of prognostic factors and their interaction. This evidence concerns the gene ERBB2 and breast cancer.